0
21

In This Issue
  |  
FOCUS
Psychopharmacology: Treatment-Resistant Disorders
Fall 2010, Vol. 8, No. 4
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

FROM THE GUEST EDITOR
From the Guest Editor
Charles B. Nemeroff, M.D., Ph.D.
CLINICAL SYNTHESIS
CME   Advances in the Management of Treatment- Resistant Schizophrenia
Jacob S. Ballon, M.D.; Jeffrey A. Lieberman, M.D.
CME   Advances in the Management of Treatment-Resistant Depression
Paul E. Holtzheimer, M.D.
CME   Advances in the Management of Treatment-Resistant Anxiety Disorders
Nicole M. Lanouette, M.D.; Murray B. Stein, M.D., M.P.H.
CME   New Vistas in the Management of Treatment-Refractory Psychiatric Disorders: Genomics and Personalized Medicine
Amanda J. Myers, Ph.D.; Charles B. Nemeroff, M.D., Ph.D.
Patient Management Exercise: Psychopharmacology: Treatment-Resistant Disorders
Ian A. Cook, M.D.
Ethics Commentary Ethics in Psychopharmacology Research
Laura Weiss Roberts, M.D., M.A.; Thomas Heinrich, M.D.
Ask the Expert: Sexual Dysfunction Medication, Hormones, and Nutrition
Barbara Bartlik, M.D.
INFLUENTIAL PUBLICATIONS
Bibliography: for Psychopharmacology: Treatment-Resistant Disorders
Abstracts: for Psychopharmacology Treatment-Resistant Disorders
Does Switching to a New Antipsychotic Improve Outcomes? Data from the CATIE Trial
Robert A Rosenheck; Sonia Davis; Nancy Covell; Susan Essock; Marvin Swart; Scott Stroup; Joseph McEvoy; Jeffrey Lieberman
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
J. Craig Nelson, M.D.; George I. Papakostas, M.D.
Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
Andres M. Lozano; Helen S. Mayberg; Peter Giacobbe; Clement Hamani; R. Cameron Craddock; Sydney H. Kennedy
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
Charles B. Nemeroff; Richard Entsuah; Isma Benattia; Mark Demitrack; Diane M. Sloan; Michael E. Thase
Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence
J. Craig Nelson, M.D.; Kevin Delucchi, Ph.D.; Lon S. Schneider, M.D.
A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder
Helen Blair Simpson, M.D., Ph.D.; Edna B. Foa, Ph.D.; Michael R. Liebowitz, M.D.; Deborah Roth Ledley, Ph.D.; Jonathan D. Huppert, Ph.D.; Shawn Cahill, Ph.D.; Donna Vermes, M.S., N.P.P.; Andrew B. Schmidt, L.C.S.W.; Elizabeth Hembree, Ph.D.; Martin Franklin, Ph.D.; Raphael Campeas, M.D.; Chang-Gyu Hahn, M.D., Ph.D.; Eva Petkova, Ph.D.
Cognitive-Behavioral Therapy for Medication-Resistant Schizophrenia: A Review
Shanaya Rathod, M.D., MRCPsych; David Kingdon, M.D.; Peter Weiden, M.D.; Douglas Turkington, M.D.
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional Capacity, and Symptoms
Christopher R. Bowie, Ph.D.; Abraham Reichenberg, Ph.D.; Thomas L. Patterson, Ph.D.; Robert K. Heaton, Ph.D.; Philip D. Harvey, Ph.D.
Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms
Keizo Yoshida, M.D., Ph.D.; Hitoshi Takahashi, M.D., Ph.D.; Hisashi Higuchi, M.D., Ph.D.; Mitsuhiro Kamata, M.D., Ph.D.; Ken-ichi Ito, M.D., Ph.D.; Kazuhiro Sato, M.D., Ph.D.; Shingo Naito, M.D.; Tetsuo Shimizu, M.D., Ph.D.; Kunihiko Itoh, Ph.D.; Kazuyuki Inoue, M.S.C.; Toshio Suzuki, Ph.D.; Charles B. Nemeroff, M.D., Ph.D.
  |  
Copyright ©
American
Psychiatric
Association